Literature DB >> 10616027

Enhanced interleukin-6 messenger RNA expression by neuronal cells in a patient with neuropsychiatric systemic lupus erythematosus.

S Hirohata1, K Hayakawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10616027     DOI: 10.1002/1529-0131(199912)42:12<2729::AID-ANR35>3.0.CO;2-I

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  8 in total

Review 1.  Neuropsychiatric lupus.

Authors:  J G Hanly
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

2.  Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus.

Authors:  Yasuhiro Shimojima; Masayuki Matsuda; Takahisa Gono; Wataru Ishii; Shu-ichi Ikeda
Journal:  Clin Rheumatol       Date:  2005-03-02       Impact factor: 2.980

Review 3.  Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.

Authors:  Hiroshi Okamoto; Akiko Kobayashi; Hisashi Yamanaka
Journal:  J Biomed Biotechnol       Date:  2010-06-29

Review 4.  Diagnosis and management of neuropsychiatric SLE.

Authors:  John G Hanly
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

5.  Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.

Authors:  Shunsei Hirohata; Yoshiyuki Arinuma; Tamiko Yanagida; Taku Yoshio
Journal:  Arthritis Res Ther       Date:  2014-03-21       Impact factor: 5.156

6.  Brain MRI in patients with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.

Authors:  Yoshiyuki Arinuma; Hirotoshi Kikuchi; Tatsuhiko Wada; Tatsuo Nagai; Sumiaki Tanaka; Hiroshi Oba; Shunsei Hirohata
Journal:  Lupus Sci Med       Date:  2014-11-03

7.  Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.

Authors:  Tomoyuki Asano; Hiromi Ito; Yoshinobu Kariya; Kyoka Hoshi; Akioh Yoshihara; Yoshikazu Ugawa; Hideharu Sekine; Shunsei Hirohata; Yoshiki Yamaguchi; Shuzo Sato; Hiroko Kobayashi; Kiyoshi Migita; Hiromasa Ohira; Yasuhiro Hashimoto; Hiroshi Watanabe
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

8.  Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.

Authors:  Shunsei Hirohata; Yoshiyuki Arinuma; Maki Takayama; Taku Yoshio
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.